Grants and Contributions:
Title:
Participation in the Canadian co-innovation mission to the Eureka GIS and Swiss Biotech Day in Switzerland – May 2026
Agreement Number:
1042343
Agreement Value:
$5,000.00
Agreement Date:
Apr 1, 2026 - May 20, 2026
Description:
Participation in the Canadian medical biotechnology co-innovation mission to the Eureka Global Innovation Summit and Swiss Biotech Day in Switzerland – May 3 to 8, 2026.
Through this mission, BioAro proposes to showcase its technologies to the Swiss Pharma market specifically focusing on the use of PanOmiQ & Genolio for drug discovery and repurposing of existing drugs besides identifying novel targets, thrugh a multi-OMICS approach. The following sectors are being targeted through this mission, for collaborations and identification of partners for Eureka submissions:
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Calgary, Alberta, CA T2P 0L4
Reference Number:
172-2026-2027-Q1-1042343
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
787849462
Recipient Type:
For-profit organization
Recipient's Operating Name:
BioAro Inc
Recipient's Legal Name:
BioAro Inc
Federal Riding Name:
Calgary Centre
Federal Riding Number:
48004
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
621510